Cabaletta Bio outlines 2026 strategic priorities for autoimmune therapy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/18/2026

1. NVDA
2. DOO
3. ARGX
4. HD
5. FN
6. METC
7. AMZN
8. SPY
9. TSLA
10. XP

Go back to Cabaletta Bio outlines 2026 strategic priorities for autoimmune therapy
(NASDAQ: CABA) Delayed: 2.89 --0 (-0%)
Previous Close $2.89    52 Week High $ 
Open $2.89    52 Week Low $ 
Day High $2.96    P/E N/A 
Day Low $2.82    EPS $ 
Volume 2,522,467